A Retrospective Study Comparing Different Injection Approaches of 5-Aminolevulinic Acid in Patients with Non-Melanoma Skin Cancer

Skin Cancer

J Dermatolog Treat. 2020 Oct 5:1-26. doi: 10.1080/09546634.2020.1832186. Online ahead of print.


Background: 5-aminolevulinic acid through a needle-free, plum-blossom needle or conventional needle followed by photodynamic therapy are available options for non-melanoma skin cancer treatment.Aim: To compare these three techniques of injection of 5-aminolevulinic, regarding treatment response and adverse effects in patients with non-melanoma skin cancer.Patients and Methods: Non-melanoma skin cancer patients have received six cycles of 0.5 mL intralesional 20% w/v 5-aminolevulinic acid through a conventional needle (CPT cohort, n = 158), or plum-blossom needle (BPT cohort, n = 118), or needle-free injection (NPT cohort, n = 105) followed by irradiation with a red light. Data regarding treatment response and adverse effects were collected and analyzed.Results: The treatment response was higher among patients of NPT cohort than those of CPT (p = 0.012, q = 3.981) and BPT (p = 0.012, q = 3.472) cohorts. Conventional and plum-blossom needle injections therapies were reported scar, local redness, and worse cosmetic appearance in the follow-up period.Conclusions: Needle-free injection of intralesional 5-aminolevulinic acid followed by irradiation with red light therapy were reported high treatment response with manageable adverse effects for non-melanoma skin cancer patients than that of conventional and plum-blossom needle injections.Level of Evidence: III.